# Concentra Group Holdings (CON): A 37.77% Upside Potential with Robust Analyst Confidence

- Link: https://www.directorstalkinterviews.com/concentra-group-holdings-con-a-37-77-upside-potential-with-robust-analyst-confidence/4121247327
- Published: 2026-03-31T10:25:46+01:00
- Author: Madison Wilson

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a formidable player in the 
healthcare sector, specifically within the medical care facilities industry, is 
capturing the attention of investors with its compelling growth trajectory and robust
analyst confidence. With a market capitalization of $2.71 billion, this U.S.-based
company specializes in occupational health services, offering a comprehensive suite
of services including workers compensation, employer-sponsored primary care, and
telemedicine.

Concentra’s stock is currently priced at $21.05, hovering within a 52-week range
of $18.71 to $24.17. While the price has seen a negligible movement recently, the
stock’s forward P/E ratio of 12.66 suggests a potentially undervalued status when
considering future earnings. This is further underscored by its impressive revenue
growth of 15.90% and a strong return on equity of 48.07%, which signals efficient
management and profitable operations.

Investors will be particularly interested in the company’s free cash flow standing
at $126.6 million, highlighting its capacity to reinvest in growth opportunities
or return capital to shareholders. Speaking of shareholder returns, Concentra offers
a dividend yield of 1.19% with a conservative payout ratio of 19.23%, indicating
a sustainable dividend policy.

Analyst ratings further bolster the investment case for Concentra, with unanimous
buy ratings from seven analysts and no hold or sell recommendations. The stock’s
price target range of $27.00 to $31.00 implies a significant upside potential of
37.77%, with an average target price of $29.00.

Technical indicators present a mixed picture, with the stock trading below its 50-
day moving average of $22.69 but slightly above its 200-day moving average of $21.17.
The RSI (14) at 37.21 suggests the stock is nearing oversold territory, potentially
indicating a buying opportunity. However, the MACD and signal line figures hint 
at a bearish momentum that investors should monitor closely.

Concentra Group Holdings’ diversified service portfolio, including its telemedicine
platform, Concentra Telemed, and its comprehensive range of workplace health services,
positions it well to capitalize on the growing demand for occupational health services.
As the company continues to expand and innovate within the healthcare landscape,
its strategic initiatives could further drive growth and profitability.

For individual investors seeking exposure in the healthcare sector, Concentra presents
a compelling opportunity with its blend of growth potential, analyst confidence,
and strategic positioning in a critical industry. As always, potential investors
should consider their risk tolerance and conduct thorough due diligence before making
investment decisions.

Share on: